F. Mulot

Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial

P. Gestraud, O. Mariani, A. Vincent-Salomon, 2014, British Journal of Cancer.

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial

X Paoletti, V. Servois, X. Paoletti, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.